About: Diagnosis and Treatment of Pulmonary Embolism During the COVID-19 Pandemic: A Position Paper from the National PERT Consortium

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Diagnosis and Treatment of Pulmonary Embolism During the COVID-19 Pandemic: A Position Paper from the National PERT Consortium Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Diagnosis and Treatment of Pulmonary Embolism During the COVID-19 Pandemic: A Position Paper from the National PERT Consortium
Creator	Morris, Timothy Channick, Richard Davis, George Giri, Jay Grodzin, Charles Horowitz, James Kabrhel, Christopher Lookstein, Robert Merli, Geno Rivera-Lebron, Belinda Rosovsky, Rachel Rosenfield, Kenneth Tapson, Victor Todoran, Thomas Weinberg, Aaron
source	Elsevier; PMC
abstract	The co-existence of COVID-19 and PE, two life threatening illnesses, in the same patient presents a unique challenge. Recent guidelines have delineated how best to diagnose and manage patients with PE. However, the unique aspects of this virus confound both the diagnosis and treatment of PE, and thus require modification of established algorithms.1-6 Important considerations include adjustment of diagnostic modalities, incorporation of the pro-thrombotic contribution of COVID-19, management of two critical cardio-respiratory illnesses in the same patient, and protecting patients and health care workers while providing optimal care. The benefits of a team-based approach for decision-making and coordination of care, such as that offered by pulmonary embolism response teams (PERT), has become more evident in this crisis. The importance of careful followup care also is underscored for patients with these two diseases with long-term effects. This position paper from the PERT Consortium specifically addresses issues related to the diagnosis and management of PE in the COVID-19 patient.
has issue date	2020-08-27(xsd:dateTime)
bibo:doi	10.1016/j.chest.2020.08.2064
has license	els-covid
sha1sum (hex)	e76dee3d98158375c02db9f9651aff610b3906a5
schema:url	https://doi.org/10.1016/j.chest.2020.08.2064
resource representing a document's title	Diagnosis and Treatment of Pulmonary Embolism During the COVID-19 Pandemic: A Position Paper from the National PERT Consortium
has PubMed Central identifier	PMC7450258
schema:publication	Chest
resource representing a document's body	covid:e76dee3d98158375c02db9f9651aff610b3906a5#body_text
is schema:about of	named entity 'BMI' named entity 'LMWH' named entity 'CrCl' named entity 'creatinine clearance' named entity 'Chest' named entity 'embolism' named entity 'ventricular' named entity 'During' named entity 'Journal' named entity 'Diagnosis' named entity 'Pulmonary Embolism' named entity 'COVID-19' named entity 'INTENSIVE CARE UNIT' named entity 'VENTRICULAR' named entity 'PHYSICIANS' named entity 'CTA' named entity 'PROSTATE SPECIFIC ANTIGEN' named entity 'AMERICAN' named entity 'PULMONARY EMBOLISM' named entity 'ULTRASOUND' named entity 'UNITS' named entity 'EXTRA' named entity 'SUBCUTANEOUS ROUTE' named entity 'LOW MOLECULAR WEIGHT HEPARIN' named entity 'Abbreviation' named entity 'team' named entity 'PSA' named entity 'computed tomography angiography' named entity 'ECMO' named entity 'Diagnosis' named entity 'UFH' named entity 'echocardiogram' named entity 'low molecular weight heparin' named entity 'extra-corporeal membrane oxygenation' named entity 'CrCl' named entity 'venous thromboembolism' named entity 'PSA' named entity 'COVID-19 Pandemic' named entity 'Position Paper' named entity 'Pulmonary Embolism' named entity 'physical findings' named entity 'thrombolysis' named entity 'thrombosis' named entity 'pulmonary embolism' named entity 'COVID-19' named entity 'COVID' named entity 'operating room' named entity 'D-dimer' named entity 'neurosurgical' named entity 'hemodynamic' named entity 'vascular medicine' named entity 'contraindicated' named entity 'DVT' named entity 'co-morbid' named entity 'COVID -19' named entity 'multi-disciplinary' named entity 'medical therapy' named entity 'viral transmission' named entity 'multi-disciplinary' named entity 'medical therapy' named entity 'multi-disciplinary approach' named entity 'thromboembolic events' named entity 'anticoagulation' named entity 'diagnostic evaluation' named entity 'Pulmonary Embolism' named entity 'risk-benefit ratio' named entity 'personal protective equipment (PPE' named entity 'viral disease' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software